Extracellular vesicles derived from bone marrow mesenchymal stem cells repair functional and structural rat adrenal

Eman Mohamed Faruk1, Wardah Abdullah Alasmari2, Hanan Fouad3

  • 1Department of Histology and Cell Biology, Faculty of Medicine, Benha University, Benha, Egypt.

Life Sciences
|January 28, 2021
PubMed

Insights

Extracellular vesicles from bone marrow mesenchymal stem cells (BMSC-EVs) show therapeutic potential against fluoride-induced adrenal toxicity. BMSC-EVs treatment repaired adrenal damage and restored function in rats exposed to sodium fluoride.

Area of Science:

  • Endocrinology
  • Toxicology
  • Regenerative Medicine

Background:

  • Adrenal glands are susceptible to toxic damage.
  • Fluoride exposure can induce adrenal toxicity.
  • Extracellular vesicles (EVs) are emerging therapeutic agents.

Purpose of the Study:

  • To investigate the therapeutic effects of bone marrow mesenchymal stem cell-derived extracellular vesicles (BMSC-EVs) on fluoride-induced adrenal toxicity in a rat model.
  • To evaluate the protective mechanisms of BMSC-EVs against sodium fluoride (NaF)-induced damage.

Main Methods:

  • Isolation and characterization of BMSC-EVs.
  • Induction of adrenal toxicity in rats using sodium fluoride (NaF).
  • Administration of BMSC-EVs and assessment of adrenal function through biochemical markers, hormone levels (ACTH, corticosterone), gene expression, and histopathology.

Main Results:

  • NaF exposure significantly impaired adrenal antioxidant capacity, increased oxidative stress, altered hormone levels, and caused histopathological damage.
  • BMSC-EVs treatment effectively counteracted NaF-induced oxidative stress and hormonal imbalances.
  • Histopathological examination revealed that BMSC-EVs significantly repaired NaF-induced adrenal tissue lesions.

Conclusions:

  • BMSC-EVs demonstrate significant therapeutic utility in mitigating fluoride-induced adrenal toxicity.
  • BMSC-EVs promote adrenal tissue repair and functional recovery by activating regenerative processes.
  • This study highlights the potential of BMSC-EVs as a novel therapeutic strategy for adrenal toxicities.